Does Incorporation of EPA and DHA in Lipoproteins Differ According to Apolipoprotein E Genotype?

Plain-language summary

This study investigated whether the way the omega-3 fatty acids EPA and DHA are incorporated into lipoproteins differs according to Apolipoprotein E genotype. It enrolled healthy men and women aged 20 to 35. It was conducted as a trial with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Université de Sherbrooke

Intervention

omega-3 fatty acids

Start date

2/1/2011

Estimated completion

5/1/2012

Countries

Canada

Related genes

Locations

• Sherbrooke, Canada

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Fifty healthy men and fifty healthy women aged between 20-35 y old will be recruited.

Exclusion Criteria:

* Tobacco
* Medication (except for oral contraceptives)
* EPA+DHA supplements
* Cancer
* Recent major surgery (\< 2 years)
* Ongoing or past severe drug or alcohol abuse
* History of psychiatric difficulties or depression
* Allergy to seafood
* Elite level of physical training
* Pregnancy and breastfeeding